tepoxalin has been researched along with cyclosporine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chourmouzis, E; Fung-Leung, WP; Lau, CY; Panakos, JA; Pope, BL | 1 |
| Argentieri, D; Barbone, AG; Lau, CY; Ritchie, D; Wang, EY; Zhou, L | 1 |
2 other study(ies) available for tepoxalin and cyclosporine
| Article | Year |
|---|---|
Tepoxalin, a novel immunomodulatory compound, synergizes with CsA in suppression of graft-versus-host reaction and allogeneic skin graft rejection.
Topics: Animals; Cyclosporine; Graft Rejection; Graft Survival; Graft vs Host Reaction; Immunosuppressive Agents; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; NF-kappa B; Pyrazoles; Skin Transplantation | 1995 |
Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
Topics: Base Sequence; Cell Line; Cyclosporine; Humans; Immunosuppressive Agents; Interleukin-2; Ionomycin; Lymphocyte Activation; Molecular Sequence Data; Muromonab-CD3; Polymerase Chain Reaction; Pyrazoles; Receptors, Interleukin-2; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate | 1994 |